This service qualitatively evaluates an antibody's specificity to ensure it primarily binds to its intended target. Methods like immunoprecipitation (IP) followed by mass spectrometry (IP-MS) are used to identify all proteins that an antibody binds to in a complex mixture, providing an unbiased and comprehensive profile of its binding partners. This helps identify any unintended off-target binding, which can lead to misleading research results or adverse effects in a therapeutic context.
Antibody Affinity & Specificity Measurement Services
Introduction of Antibody Affinity & Specificity Measurement
Antibody affinity and specificity are key determinants of a biotherapeutic's function and a research tool's reliability. In early drug discovery, a deep understanding of these binding characteristics is essential for predicting an antibody's pharmacological and pharmacodynamic profile, ultimately improving the chances of successful clinical translation. Our services provide the definitive data needed to confidently advance your projects from early-stage discoveries to clinical trials.
Applications of Antibody Affinity & Specificity Measurement
Accurate antibody characterization is central to several key applications in life sciences. It helps select optimal candidates by correlating affinity and specificity with desired functional outcomes, such as neutralizing activity or immune cell engagement. This is crucial for novel formats like bispecifics and ADCs. It also provides the necessary quantitative data for pharmacokinetic/pharmacodynamic (PK/PD) studies, helping to understand an antibody's half-life, distribution, and efficacy in vivo.
Our Antibody Affinity & Specificity Measurement Services
Creative Biolabs provides a range of services to thoroughly characterize antibodies, focusing on their specificity, binding kinetics, and cross-reactivity. These services are crucial for selecting and developing effective biotherapeutics, diagnostics, and research tools.
Flow Cytometry (FC) based Antibody-Cell Binding Evaluation Services
This service assesses an antibody's ability to bind to target antigens expressed on the surface of living cells. Using flow cytometry, researchers can determine the binding affinity and potency of therapeutic candidates by testing them against a range of cell lines or primary cells at various concentrations. This method is especially useful for evaluating antibodies targeting cell-surface receptors and other membrane-bound proteins.
Antibody Binding Kinetic Measurement Services
This service provides quantitative data on the real-time binding dynamics of an antibody and its antigen. Key parameters measured include the association rate (kon), the dissociation rate (koff), and the equilibrium dissociation constant (KD). Techniques such as Surface Plasmon Resonance (SPR) and Bio-Layer Interferometry (BLI) are used to perform these measurements in a label-free manner, offering high-throughput and detailed kinetic information. This data is essential for screening lead candidates and optimizing an antibody's function.
Antibody Cross-Reactivity Evaluation Services
Cross-reactivity refers to an antibody's ability to bind to multiple, structurally similar epitopes on different antigens. This service identifies and assesses any "unintentional" binding that could lead to safety concerns in clinical trials or inaccurate results in diagnostics. Services may include:
- In silico homology searches, which compare the antibody's sequence to a database of human proteins to predict potential cross-reactivity.
- In vitro binding assays, which test the antibody against a library of purified proteins or peptides.
- Immunohistochemistry (IHC) studies, which assess binding to a comprehensive panel of human and animal tissues to identify off-target binding sites.
Creative Biolabs' workflow is designed to provide a comprehensive and transparent service, ensuring clients receive actionable data to drive their projects forward.
Fig. 1 The workflow of Antibody Affinity & Specificity Measurement Services
Our Antibody Affinity & Specificity Measurement Platforms
Creative Biolabs employs a suite of cutting-edge technologies to provide comprehensive antibody characterization:
Surface Plasmon Resonance (SPR)
This gold-standard, label-free technique provides real-time data on the association (kon) and dissociation (koff) rates, from which the equilibrium dissociation constant (KD) is calculated. It is highly sensitive and ideal for kinetic analysis of purified components.
Flow Cytometry (FC)
An on-cell method that measures antibody binding to target antigens in their native three-dimensional state on the cell surface. This approach is invaluable for evaluating avidity, the combined strength of multiple binding events, which is crucial for predicting in vivo behavior.
Immunoprecipitation followed by Mass Spectrometry (IP-MS)
An unbiased technique used for comprehensive specificity profiling. It identifies all proteins that an antibody binds to within a complex biological sample, including both intended targets and any off-target proteins, providing a definitive profile of its binding partners.
ELISA-based Assays
We utilize advanced ELISA methods not only for traditional titer and concentration measurements but also for quantitative analysis of cross-reactivity and sensitivity (IC50). Our proprietary data analysis accounts for background noise, providing more accurate and reliable results than conventional methods.
Published Data
Previous research indicated that the heavy chain complementarity-determining regions (CDRs) are the primary cause of this non-specific binding. The researchers focused on co-optimizing the affinity (on-target binding) and specificity (low non-specific binding) of the therapeutic antibody. A large library of antibody variants, with mutations in the heavy chain CDRs, was created and sorted using fluorescence-activated cell sorting (FACS) for high and low levels of non-specific binding to two different polyspecificity reagents.
Fig. 2 Evaluation of affinities and specificities for antibody mutants.1
Contact Us
Creative Biolabs provides unmatched expertise and advanced technology for antibody characterization. Our unique approach of integrating multiple technologies ensures you get the full picture of your antibody's behavior. We can help you navigate the complexities of affinity, avidity, and specificity, enabling you to make confident, data-driven decisions. Creative Biolabs is your trusted partner in antibody development. Contact us today to discuss your project.
References
- Makowski, Emily K., et al. "Co-optimization of therapeutic antibody affinity and specificity using machine learning models that generalize to novel mutational space." Nature communications 13.1 (2022): 3788. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.1038/s41467-022-31457-3
For research use only. Not intended for any clinical use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
